The αvβ3 integrin participates in cell morphogenesis, growth factor signaling, and cell survival. Activation of the integrin is central to these processes and is influenced by specific ECM components, which engage both integrins and syndecans. This paper demonstrates that the αvβ3 integrin and syndecan-1 (S1) are functionally coupled. The integrin is dependent on the syndecan to become activated and to mediate signals required for MDA-MB-231 and MDA-MB-435 human mammary carcinoma cell spreading on vitronectin or S1-specific antibody. Coupling of the syndecan to αvβ3 requires the S1 ectodomain (ED), as ectopic expression of glycosylphosphatidylinositol-linked S1ED enhances αvβ3 recognition of vitronectin; and treatments that target this domain, including competition with recombinant S1ED protein or anti-S1ED antibodies, mutation of the S1ED, or down-regulation of S1 expression by small-interfering RNAs, disrupt αvβ3-dependent cell spreading and migration. Thus, S1 is likely to be a critical regulator of many cellular behaviors that depend on activated αvβ3 integrins.
Skip Nav Destination
Article navigation
11 October 2004
Article|
October 11 2004
The syndecan-1 ectodomain regulates αvβ3 integrin activity in human mammary carcinoma cells
DeannaLee M. Beauvais,
DeannaLee M. Beauvais
Department of Pathology and Laboratory Medicine and Program in Molecular and Cellular Pharmacology, University of Wisconsin-Madison, Madison, WI 53706
Search for other works by this author on:
Brandon J. Burbach,
Brandon J. Burbach
Department of Pathology and Laboratory Medicine and Program in Molecular and Cellular Pharmacology, University of Wisconsin-Madison, Madison, WI 53706
Search for other works by this author on:
Alan C. Rapraeger
Alan C. Rapraeger
Department of Pathology and Laboratory Medicine and Program in Molecular and Cellular Pharmacology, University of Wisconsin-Madison, Madison, WI 53706
Search for other works by this author on:
DeannaLee M. Beauvais
Department of Pathology and Laboratory Medicine and Program in Molecular and Cellular Pharmacology, University of Wisconsin-Madison, Madison, WI 53706
Brandon J. Burbach
Department of Pathology and Laboratory Medicine and Program in Molecular and Cellular Pharmacology, University of Wisconsin-Madison, Madison, WI 53706
Alan C. Rapraeger
Department of Pathology and Laboratory Medicine and Program in Molecular and Cellular Pharmacology, University of Wisconsin-Madison, Madison, WI 53706
Correspondence to Alan C. Rapraeger: [email protected]
Abbreviations used in this paper: COL, collagen; ED, ectodomain; FN, fibronectin; GPI, glycosylphosphatidylinositol; Hb, Hepes-buffered; HS, heparan sulfate; hS1, human S1; IMD, integrin-mediated death; LN, laminin; mS1, mouse S1; pAb, polyclonal antibody; S1, syndecan-1; siRNA, small-interfering RNA; TM, transmembrane; VN, vitronectin.
Received:
April 28 2004
Accepted:
August 23 2004
Online ISSN: 1540-8140
Print ISSN: 0021-9525
The Rockefeller University Press
2004
J Cell Biol (2004) 167 (1): 171–181.
Article history
Received:
April 28 2004
Accepted:
August 23 2004
Citation
DeannaLee M. Beauvais, Brandon J. Burbach, Alan C. Rapraeger; The syndecan-1 ectodomain regulates αvβ3 integrin activity in human mammary carcinoma cells . J Cell Biol 11 October 2004; 167 (1): 171–181. doi: https://doi.org/10.1083/jcb.200404171
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement
Advertisement